Preconditioning and stem cell survival

Journal of Cardiovascular Translational Research

Volumn 3, Issue 2, 2010, Pages 89-102

  Haider, Husnain Kh ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Ischemia; Myocardial infarction; Preconditioning; Stem cells

Indexed keywords

MICRORNA; RECOMBINANT GROWTH FACTOR; SIGNAL PEPTIDE;

AUTOCRINE EFFECT; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; GENE OVEREXPRESSION; GENETIC MANIPULATION; HEART MUSCLE; HUMAN; ISCHEMIC PRECONDITIONING; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE REGENERATION; TRANSGENICS; ANIMAL; APOPTOSIS; BIOSYNTHESIS; DRUG EFFECTS; GENE THERAPY; GENETICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; STEM CELL TRANSPLANTATION; TIME; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CYTOPROTECTION; GENE THERAPY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIC PRECONDITIONING; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; TREATMENT OUTCOME; GENETIC THERAPY;

EID: 77953617367     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9161-2     Document Type: Review

References (127)

1. Abbott, J. D., Huang, Y., et al. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110(21), 3300-3335
2. Abdul Kadir, S. H., Ali, N. N., et al. (2009). Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease. Journal of Cellular and Molecular Medicine (in press)
3. Addya, S., Shiroto, K., et al. (2005). Ischemic preconditioningmediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice. Journal of Molecular and Cellular Cardiology, 38(2), 345-351.
4. Afzal, M. R., Haider, K. H., et al. (2009). Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxidants & redox signalling (in press)
5. Ahmad, N., Wang, Y., et al. (2006). Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. American Journal of Physiology. Heart and Circulatory Physiology, 290 (6), H2402-H2408.
6. Akao, M., Ohler, A., et al. (2001). Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circulation Research, 88(12), 1267-1275.
7. Akita, T., Murohara, T., et al. (2003). Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Laboratory Investigation, 83(1), 65-73.
8. Anversa, P., Leri, A., et al. (2006). Cardiac regeneration. Journal of the American College of Cardiology, 47(9), 1769-1776.
9. Asahara, T., Chen, D., et al. (1998). Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circulation Research, 83(3), 233-240.
10. Askari, A. T., Unzek, S., et al. (2003). Effect of stromal-cellderived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 362(9385), 697-703.
11. Azarnoush, K., Maurel, A., et al. (2005). Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. Journal of Thoracic and Cardiovascular Surgery, 130(1), 173-179.
12. Baines, C. P., Pass, J. M., et al. (2001). Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning. Basic Research in Cardiology, 96(3), 207-218.
13. Baldi, A., Abbate, A., et al. (2002). Apoptosis and postinfarction left ventricular remodeling. Journal of Molecular and Cellular Cardiology, 34(2), 165-174.
14. Bartunek, J., Croissant, J. D., et al. (2007). Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. American Journal of Physiology. Heart and Circulatory Physiology, 292(2), H1095-H1104.
15. Behfar, A., Perez-Terzic, C., Faustino, R. S., Arrell, D. K., Hodgson, D. M., Yamada, S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine, 204, 405-420.
16. Bellis, A., Castaldo, D., et al. (2009). Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(8), 1207-1212.
17. Bolli, R. (2000). The late phase of preconditioning. Circulation Research, 87(11), 972-983.
18. Budas, G. R., Churchill, E. N., et al. (2007). Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacological Research, 55(6), 523-536.
19. Busija, D. W., Katakam, P., et al. (2005). Effects of ATPsensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Research Bulletin, 66(2), 85-90.
20. Camirand, G., Caron, N. J., et al. (2002). Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation, 73(3), 453-461.
21. Chen, M., Xie, H. Q., et al. (2008). Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro. Cell Proliferation, 41(2), 336-347.
22. Crisostomo, P. R., Abarbanell, A. M., et al. (2008). Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. American Journal of Physiology. Heart and Circulatory Physiology, 295 (4), H1726-H1735.
23. Crosby, M. E., Kulshreshtha, R., et al. (2009). MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Research, 69(3), 1221-1229.
24. Das, R., Jahr, H., et al. (2009). The role of hypoxia in MSCs: Considerations for regenerative medicine approaches. Tissue Engineering Part B Reviews (in press)
25. Dawn, B., Abdel-Latif, A., et al. (2009). Cardiac repair with adult bone marrow-derived cells: The clinical evidence. Antioxidants & Redox Signalling, 11, 1865-1882.
26. DeBusk, L. M., Hallahan, D. E., et al. (2004). Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Experimental Cell Research, 298(1), 167-177.
27. Devarajan, E., & Huang, S. (2009). STAT3 as a central regulator of tumor metastases. Current Molecular Medicine, 9(5), 626-633.
28. Dzau, V. J., Gnecchi, M., et al. (2005). Enhancing stem cell therapy through genetic modification. Journal of the American College of Cardiology, 46(7), 1351-1353.
29. Elmadbouh, I., Haider, H., et al. (2007). Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 42(4), 792-803.
30. Farahmand, P., Lai, T. Y., et al. (2008). Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation, 118(14 Suppl), S130-S137.
31. Fasanaro, P., D'Alessandra, Y., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry, 283(23), 15878-15883.
32. Gross, G. J., & Auchampach, J. A. (1992). Blockade of ATPsensitive potassium channels prevents myocardial preconditioning in dogs. Circulation Research, 70(2), 223-233.
33. Haider, H., & Ashraf, M. (2008). Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. Journal of Molecular and Cellular Cardiology, 45(4), 554-566.
34. Haider, H., Jiang, S. J., et al. (2004). Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplantation Proceedings, 36(1), 232-235.
35. Haider, H., Jiang, S., et al. (2008). IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circulation Research, 103(11), 1300-1308.
36. Haider, H., Tan, A. C., et al. (2004). Myoblast transplantation for cardiac repair: A clinical perspective. Molecular Therapy, 9(1), 14-23.
37. Hausenloy, D. J., & Yellon, D. M. (2006). Survival kinases in ischemic preconditioning and postconditioning. Cardiovascular Research, 70(2), 240-253.
38. Heads, R. J., Yellon, D. M., et al. (1995). Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cells. Journal of Molecular and Cellular Cardiology, 27(8), 1669-1678.
39. Hiasa, K., Ishibashi, M., et al. (2004). Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: Next-generation chemokine therapy for therapeutic neovascularization. Circulation, 109 (20), 2454-2461.
40. Hodgetts, S. I., Beilharz, M. W., et al. (2000). Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplantation, 9(4), 489-502.
41. Hodgetts, S. I., & Grounds, M. D. (2001). Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. Immunology and Cell Biology, 79(3), 231-239.
42. Hu, X., Dai, S., et al. (2007). Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation, 116(6), 654-663.
43. Hu, X., Yu, S. P., et al. (2008). Transplantation of hypoxiapreconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Journal of Thoracic and Cardiovascular Surgery, 135(4), 799-808.
44. Huangfu, D., Osafune, K., et al. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology, 26(11), 1269-1275.
45. Ii, M., Nishimura, H., et al. (2005). Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation, 111(9), 1114-1120.
46. Ivan, M., Harris, A. L., et al. (2008). Hypoxia response and microRNAs: No longer two separate worlds. Journal of Cellular and Molecular Medicine, 12(5A), 1426-1431.
47. Jiang, S., Haider, H., et al. (2006). Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circulation Research, 99(7), 776-784.
48. Kamota, T., Li, T. S., et al. (2009). Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. Journal of the American College of Cardiology, 53(19), 1814-1822.
49. Kanemitsu, N., Tambara, K., et al. (2006). Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model. Journal of Heart and Lung Transplantation, 25(10), 1253-1262.
50. Kharbanda, R. K., Mortensen, U. M., et al. (2002). Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation, 106(23), 2881-2883.
51. Khoynezhad, A., Jalali, Z., et al. (2004). Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon. Annals of Thoracic Surgery, 78(3), 1109-1118.
52. Kicinska, A., & Szewczyk, A. (2003). Protective effects of the potassium channel opener-diazoxide against injury in neonatal rat ventricular myocytes. General Physiology and Biophysics, 22 (3), 383-395.
53. Kim, H. W., Haider, H. K., et al. (2009). Ischemic preconditioning augments survival of stem cells via MIR-210 expression by targeting caspase-8 associated protein 2. Journal of Biological Chemistry, 284, 33161-33168.
54. Kim, I., Kim, H. G., et al. (2000). Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circulation Research, 86(9), 952-959.
55. Kis, B., Nagy, K., et al. (2004). The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. NeuroReport, 15(2), 345-349.
56. Kofidis, T., de Bruin, J. L., et al. (2004). Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells, 22(7), 1239-1245.
57. Koh, G. Y., Klug, M. G., et al. (1993). Differentiation and longterm survival of C2C12 myoblast grafts in heart. Journal of Clinical Investigation, 92(3), 1548-1554.
58. Koh, G. Y., Soonpaa, M. H., et al. (1993). Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. American Journal of Physiology, 264(5 Pt 2), H1727-H1733.
59. Kolossov, E., Bostani, T., et al. (2006). Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. Journal of Experimental Medicine, 203(10), 2315-2327.
60. Konstantinov, I. E., Arab, S., et al. (2005). The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium. Journal of Thoracic and Cardiovascular Surgery, 130(5), 1326-1332.
61. Kubo, M., Li, T. S., et al. (2008). Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance. American Journal of Physiology. Heart and Circulatory Physiology, 294 (2), H590-H595.
62. Kudo, M., Wang, Y., et al. (2002). Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. American Journal of Physiology. Heart and Circulatory Physiology, 283(1), H296-H301.
63. Kudo, M., Wang, Y., et al. (2003). Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. Journal of Molecular and Cellular Cardiology, 35(9), 1113-1119.
64. Kulshreshtha, R., Davuluri, R. V., et al. (2008). A microRNA component of the hypoxic response. Cell Death and Differentiation, 15(4), 667-671.
65. Kulshreshtha, R., Ferracin, M., et al. (2007). Regulation of microRNA expression: the hypoxic component. Cell Cycle, 6 (12), 1426-1431.
66. Kutschka, I., Chen, I. Y., et al. (2006). Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation, 114(1 Suppl), I167-I173.
67. Kutschka, I., Kofidis, T., et al. (2006). Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation, 114(1 Suppl), I174-I180.
68. Laflamme, M. A., Chen, K. Y., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015-1024.
69. Lataillade, J. J., Domenech, J., et al. (2004). Stromal cell-derived factor-1 (SDF-1)\CXCR4 couple plays multiple roles on haematopoietic progenitors at the border between the old cytokine and new chemokine worlds: Survival, cell cycling and trafficking. European Cytokine Network, 15(3), 177-188.
70. Li, W., Ma, N., et al. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 25(8), 2118-2127.
71. Liu, T. B., Fedak, P. W., et al. (2004). Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. American Journal of Physiology. Heart and Circulatory Physiology, 287(6), H2840-H2849.
72. Logue, S. E., Gustafsson, A. B., et al. (2005). Ischemia/reperfusion injury at the intersection with cell death. Journal of Molecular and Cellular Cardiology, 38(1), 21-33.
73. Lu, G., Haider, H. K., et al. (2009). Sca-1+ stem cell survival and engraftment in the infarcted heart: Dual role for preconditioninginduced connexin-43. Circulation, 119(19), 2587-2596.
74. Mahboubi, K., Biedermann, B. C., et al. (2000). IL-11 activates human endothelial cells to resist immune-mediated injury. Journal of Immunology, 164(7), 3837-3846.
75. Makkar, R. R., Price, M. J., et al. (2005). Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. Journal of Cardiovascular Pharmacology Therapy, 10(4), 225-233.
76. Mangi, A. A., Noiseux, N., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9(9), 1195-1201.
77. Matsui, T., Tao, J., et al. (2001). Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation, 104(3), 330-335.
78. Matsumoto, R., Omura, T., et al. (2005). Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(6), 1168-1173.
79. Muller-Ehmsen, J., Whittaker, P., et al. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. Journal of Molecular and Cellular Cardiology, 34 (2), 107-116.
80. Mummery, C., van der Heyden, M. A., et al. (2007). Cardiomyocytes from human and mouse embryonic stem cells. Methods in Molecular Medicine, 140, 249-272.
81. Murry, C. E., Jennings, R. B., et al. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74(5), 1124-1136.
82. Nadal-Ginard, B., Anversa, P., et al. (2005). Cardiac stem cells and myocardial regeneration. Novartis Foundation Symposium, 265, 142-154.
83. Nakamura, T., & Schneider, M. D. (2003). The way to a human's heart is through the stomach: Visceral endoderm-like cells drive human embryonic stem cells to a cardiac fate. Circulation, 107 (21), 2638-2639.
84. Nakamura, Y., Yasuda, T., et al. (2006). Enhanced cell transplantation: Preventing apoptosis increases cell survival and ventricular function. American Journal of Physiology. Heart and Circulatory Physiology, 291(2), H939-H947.
85. Nanduri, J., Yuan, G., et al. (2008). Transcriptional responses to intermittent hypoxia. Respiratory Physiology and Neurobiology, 164(1-2), 277-281.
86. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5), 408-416.
87. Niagara, M. I., Haider, H., et al. (2007). Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circulation Research, 100(4), 545-555.
88. Okita, K., Nakagawa, M., et al. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322 (5903), 949-953.
89. O'Sullivan, J. C., Yao, X. L., et al. (2007). Diazoxide, as a postconditioning and delayed preconditioning trigger, increases HSP25 and HSP70 in the central nervous system following combined cerebral stroke and hemorrhagic shock. Journal of Neurotrauma, 24(3), 532-546.
90. Pagani, F. D., DerSimonian, H., et al. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. Journal of the American College of Cardiology, 41(5), 879-888.
91. Pasha, Z., Wang, Y., et al. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77(1), 134-142.
92. Patel, H. H., Gross, E. R., et al. (2005). Sarcolemmal KATP channel triggers delayed ischemic preconditioning in rats. American Journal of Physiology. Heart and Circulatory Physiology, 288(1), H445-H447.
93. Pillarisetti, K., & Gupta, S. K. (2001). Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation, 25(5), 293-300.
94. Qu, Z., Balkir, L., et al. (1998). Development of approaches to improve cell survival in myoblast transfer therapy. Journal of Cell Biology, 142(5), 1257-1267.
95. Rajapakse, N., Kis, B., et al. (2003). Diazoxide pretreatment induces delayed preconditioning in astrocytes against oxygen glucose deprivation and hydrogen peroxide-induced toxicity. Journal of Neuroscience Research, 73(2), 206-214.
96. Ravingerova, T., Matejikova, J., et al. (2007). Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. Molecular and Cellular Biochemistry, 297(1-2), 111-120.
97. Rosova, I., Dao, M., et al. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells, 26(8), 2173-2182.
98. Rothwarf, D. M., & Karin, M. (1999). The NF-kappa B activation pathway: A paradigm in information transfer from membrane to nucleus. Science's STKE: Signal Transduction Knowledge Environment, 1999(5), RE1.
99. Saito, T., Kuang, J. Q., et al. (2002). Xenotransplant cardiac chimera: Immune tolerance of adult stem cells. Annals of Thoracic Surgery, 74(1), 19-24. discussion 24.
100. Sato, T., Li, Y., et al. (2004). Minoxidil opens mitochondrial K (ATP) channels and confers cardioprotection. British Journal of Pharmacology, 141(2), 360-366.
101. Shimizu, M., Tropak, M., et al. (2009). Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clinical Science (London), 117(5), 191-200.
102. Shintani, S., Kusano, K., et al. (2006). Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nature Clinical Practice. Cardiovascular Medicine, 3(Suppl 1), S123-S128.
103. Shmelkov, S. V., Meeus, S., et al. (2005). Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue. Circulation, 111(9), 1175-1183.
104. Shyu, W. C., Lin, S. Z., et al. (2008). Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. Journal of Pharmacology and Experimental Therapeutics, 324(2), 834-849.
105. Singla, D. K. (2009). Embryonic stem cells in cardiac repair and regeneration. Antioxidants & Redox Signalling, 11, 1857-1863.
106. Sommer, C. A., Stadtfeld, M., et al. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3), 543-549.
107. Stein, A. B., Bolli, R., et al. (2007). The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis. Journal of Molecular and Cellular Cardiology, 42(6), 1075-1085.
108. Strauer, B. E., Ott, G., et al. (2009). Bone marrow cells to improve ventricular function. Heart, 95(2), 98-99.
109. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
110. Takashi, E., Wang, Y., et al. (1999). Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circulation Research, 85(12), 1146-1153.
111. Tang, Y. L., Zhu, W., et al. (2009). Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circulation Research, 104(10), 1209-1216.
112. Tateishi, K., Takehara, N., et al. (2008). Stemming heart failure with cardiac-or reprogrammed-stem cells. Journal of Cellular and Molecular Medicine, 12(6A), 2217-2232.
113. Theus, M. H., Wei, L., et al. (2008). In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology, 210(2), 656-670.
114. Toma, C., Pittenger, M. F., et al. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93-98.
115. Wang, Y., & Ashraf, M. (1999). Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. Circulation Research, 84(10), 1156-1165.
116. Wang, Y., Takashi, E., et al. (2001). Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation, 104(1), 85-90.
117. 2-induced cell death. American Journal of Respiratory Cell and Molecular Biology, 29(4), 513-522.
118. Winkler, J., Hescheler, J., et al. (2005). Embryonic stem cells for basic research and potential clinical applications in cardiology. Biochimica et Biophysica Acta, 1740(2), 240-248.
119. Xu, M., Wang, Y., et al. (2001). Mitochondrial K(ATP) channel activation reduces anoxic injury by restoring mitochondrial membrane potential. American Journal of Physiology. Heart and Circulatory Physiology, 281(3), H1295-H1303.
120. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 1(1), 39-49.
121. Yamaoka, M., Yamaguchi, S., et al. (2000). Apoptosis in rat cardiac myocytes induced by Fas ligand: Priming for Fas-mediated apoptosis with doxorubicin. Journal of Molecular and Cellular Cardiology, 32(6), 881-889.
122. Yao, K., Huang, R., et al. (2008). Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart, 94(9), 1147-1153.
123. Yau, T. M., Kim, C., et al. (2005). Increasing transplanted cell survival with cell-based angiogenic gene therapy. Annals of Thoracic Surgery, 80(5), 1779-1786.
124. Yu, H. M., Zhi, J. L., et al. (2006). Role of the JAK-STAT pathway in protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells. Apoptosis, 11(6), 931-941.
125. Yuan, G., Nanduri, J., et al. (2008). Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. Journal of Cellular Physiology, 217(3), 674-685.
126. Zemani, F., Silvestre, J. S., et al. (2008). Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(4), 644-650.
127. Zhao, Z. Q., & Vinten-Johansen, J. (2006). Postconditioning: Reduction of reperfusion-induced injury. Cardiovascular Research, 70(2), 200-211.